openPR Logo
Press release

Congela Biocosmetics Announces Purchase of JuveXO to Propel the Use of Exosomes in Aesthetic Medicine

02-23-2024 09:31 AM CET | Health & Medicine

Press release from: Congela Biocosmetics, LLC

Congela Biocosmetics Logo: Congela is leading the way in biocosmetic innovation, transforming the world of aesthetics.

Congela Biocosmetics Logo: Congela is leading the way in biocosmetic innovation, transforming the world of aesthetics.

Miami, Florida. Congela Biocosmetics, LLC., a biocosmetic company formulating precision, regenerative hair and skin products, announced today the acquisition of the JuveXO® brand and product line. This strategic acquisition accelerates the development of innovative biocosmetic products and will reinvent the future of aesthetics. Brian Pla steps up as the President for Congela Biocosmetics, where he will continue to lead the company, supported by his existing accomplished scientific and management team.

"Congela's vision is to pioneer and set the global standard in biocosmetics by providing diverse and continually innovative skincare products," says Brian Pla. "This strategic acquisition of JuveXO®, allows us to sustainably pursue and achieve this vision further expanding on Restem Group's extensive cell-based product history," adds Pla.

Congela Biocosmetics now becomes the sole distributor of JuveXO®, a leading topical exosome serum backed by over a decade of scientific research. Created upon the foundation of innovative stem cell research, JuveXO® provides consumers with an alternative to improve the skin's appearances in areas of common skin concerns like fine lines, wrinkles, redness, and inflammation, as well as improve the appearance of dull, damaged, and thinning hair. When used in conjunction with microneedling or fractional devices, JuveXO® penetrates deep into the skin to provide transformative regenerative results.

Congela Biocosmetics is a subsidiary of Restem Group, a leader in cellular innovation that offers substantial support to propel Congela Biocosmetics into the future of aesthetics. With the support of the Restem Group, Congela will heighten its product line, providing consumers and practitioners with the safest, most efficacious, and most innovative solutions to their skin concerns.

"Our vision is to advance science using our expertise in stem cells and riding on the incredible results already created by Congela within the biocosmetic sector," stated Rafael Gonzalez, Ph.D, Founder of Restem and Chief Scientific Officer of Congela Biocosmetics. "Witnessing the transformative potential of JuveXO®, we are very excited about the acquisition and the monumental opportunity of Congela Biocosmetics," added Dr. Gonzalez.

The future of Congela Biocosmetics is bright as it rapidly gains market share and continues to expand its product line to provide consumers and practitioners with all-encompassing cosmetic options for common skin and hair concerns, both in office and at home. Congela is launching a series of webinars to discuss the future of exosomes in biocosmetics, and will be in attendance at various aesthetic and cosmetic events throughout 2024. Congela will be kicking off their impressive 2024 conference tour at the Aesthetic & Anti-Aging Medicine World Congress in Miami, FL February 22-24. Follow this journey at www.juvexo.com.

About Congela Biocosmetics, LLC
Congela Biocosmetics, LLC is a biocosmetic company that produces precision skincare that helps restore natural beauty at the cellular level. As a leader in biological cosmetics (ie. biocosmetics), Congela has combined extensive biological research with expertise in the aesthetic industry to provide consumers and practitioners with optimal cosmetic solutions to common skin and hair concerns.

About JuveXO®
JuveXO® is a topical serum that has revolutionized aesthetic medicine by harnessing the extraordinary power of exosomes. Through the most cutting-edge biotechnology and decades of research, JuveXO® delivers a non-invasive and non-surgical method to revitalize and rejuvenate the appearance of skin and hair. JuveXO® combines biology and cosmetics to improve the look of damaged and aging tissue.

About Restem Group
Restem Group is a leading clinical-stage biopharmaceutical company focused on the discovery and development of patient-specific, as well as off-the-shelf and ready-to-use, next-generation cell therapies that are designed to activate and enhance a patient's own immune system. These therapies are designed to enable the treatment of a broad range of disabling diseases that improve patient outcomes, as well as overall health and wellness for patients around the world.

Congela Biocosmetics, LLC
1728 Coral Way Suite 600
Miami, FL 33145

Press Contact:
Heather Vest
Marketing Manager
heather@juvexo.com
https://juvexo.com/
(833)436-8372

Congela Biocosmetics is a biocosmetic company that produces precision skincare that helps restore natural beauty at the cellular level. As a leader in biological cosmetics, Congela has combined biological research with expertise in the aesthetic industry to provide practitioners with optimal cosmetic solutions to common skin and hair concerns.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Congela Biocosmetics Announces Purchase of JuveXO to Propel the Use of Exosomes in Aesthetic Medicine here

News-ID: 3395915 • Views:

More Releases for Biocosmetics

Congela Biocosmetics Introduces XO Spray, A Revolutionary Oxygen Infusion Spray
Delivering JuveXO exosomes and skincare serums directly into the skin. Image: https://www.getnews.info/uploads/a3d78ff50568f394aa57426170ea73fb.jpg Renowned for its precision skincare exosomes, Congela Biocosmetics [https://juvexo.com/pages/xo-spray] is excited to announce the launch of the XO Spray [https://juvexo.com/pages/xo-spray], a revolutionary delivery system for JuveXO exosomes and other topical serums. The leading innovator in skincare technology is further expanding its footprint by offering this skincare game-changer that enhances product application and promotes skin rejuvenation. Brian Pla, Chief Commercial Officer at
Artificial Saliva Market Size, Share, Trends, Growth Opportunities and Competiti …
"Global Artificial Saliva Market study by Data Bridge Market Research provides details about the market dynamics affecting this market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. All the market insights of large-scale Artificial Saliva market research report will lead to actionable ideas and better decision-making. This market report also takes into consideration the drivers and
Artificial Saliva Market Size, Share, Trends, Demand, Growth and Competitive Out …
Global Artificial Saliva Market study by Data Bridge Market Research provides details about the market dynamics affecting this market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. All the market insights of large-scale Artificial Saliva market research report will lead to actionable ideas and better decision-making. This market report also takes into consideration the drivers and
Cosmetic Ingredients Market is Booming at A Cagr Of 5.8% to Reach US$ 58.8 Bn by …
The latest research findings on cosmetic ingredients present a dynamic landscape of innovation, sustainability, and market expansion within the global cosmetic industry. This comprehensive analysis sheds light on the transformative shifts in cosmetic formulations, driven by a surge in demand for sustainable, bio-based, and environmentally friendly cosmetic ingredients. Key Insights on Cosmetic Ingredients: Bio-based Ingredient Adoption: Leading cosmetic companies are transitioning away from harmful, non-biodegradable ingredients derived from petroleum or mineral oils.
Artificial Saliva Industry: A Decade of Advances in Oral Health (2023-2033)
Oral disorders are the fourth most expensive condition to treat in both emerging and industrialised nations, according to data from the World Health Organisation. A significant healthcare problem that directly affects the market for artificial saliva is the cost of maintaining oral health. Since the artificial saliva market is mostly driven by consumers, rising disposable income and per-capita spending are projected to propel the industry throughout the forecast period. The Artificial
Unflavored and Flavored Birch Water Market Is Booming Worldwide with Sibberi, Tr …
The Unflavored and Flavored Birch Water Market study with 65+ market data Tables, Pie charts & Figures is now released by HTF MI. The research assessment of the Market is designed to analyze futuristic trends, growth factors, industry opinions, and industry-validated market facts to forecast till 2029. The market Study is segmented by key a region that is accelerating the marketization. This section also provides the scope of different segments